Discover
GUTS
Fractyl Health, Inc.
4.42
2 x 0.48
2 x 0.90
bid
ask
+
0.19
4.49%
2 @ 07:51 PM
4.52 +0.10 (2.26%)
| Ytd | -83.26% | |
| 1y | -73.69% |
4.20
day range
4.55
4.23
52 week range
28.44
| Open | 4.21 | Prev Close | 4.23 | Low | 4.20 | High | 4.55 | Mkt Cap | 58.63M |
| Vol | 198.30K | Avg Vol | 156.16K | EPS | -10.56 | P/E | N/A | Forward P/E | -0.77 |
| Beta | 2.42 | Short Ratio | 5.48 | Inst. Own | 86.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 7.42 | 200-d Avg | 9.77 | 1yr Est | 15.50 |
| Income Statement | |||
| Operating Expenses | 19.10M | ||
| Research and Development Expense | 13.81M | ||
| Selling, General and Administrative Expense | 5.28M | ||
| Operating Income | -19.10M | ||
| Net Income | -25.54M | ||
| Net Income Common Stock | -25.54M | ||
| Net Income Common Stock (USD) | -25.54M | ||
| Consolidated Income | -25.54M | ||
| Earnings per Basic Share | -1.92 | ||
| Earnings per Basic Share (USD) | -1.92 | ||
| Earnings per Diluted Share | -1.92 | ||
| Earning Before Interest & Taxes (EBIT) | -25.54M | ||
| Earning Before Interest & Taxes (USD) | -25.54M | ||
| Weighted Average Shares | 13.22M | ||
| Weighted Average Shares Diluted | 13.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 47.14M | ||
| Cash and Equivalents (USD) | 47.14M | ||
| Investments | 4.26M | ||
| Investments Non-Current | 4.26M | ||
| Current Assets | 49.60M | ||
| Property, Plant & Equipment Net | 27.82M | ||
| Total Assets | 81.98M | ||
| Debt Current | 5.18M | ||
| Total Debt | 60.74M | ||
| Current Liabilities | 15.74M | ||
| Debt Non-Current | 55.56M | ||
| Total Liabilities | 83.64M | ||
| Accumulated Retained Earnings (Deficit) | -572.58M | ||
| Shareholders Equity | -1.66M | ||
| Shareholders Equity (USD) | -1.66M | ||
| Assets Non-Current | 32.37M | ||
| Total Debt (USD) | 60.74M | ||
| Liabilities Non-Current | 67.91M | ||
| Trade and Non-Trade Payables | 1.01M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 714.00K | ||
| Net Cash Flow from Financing | -127.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.03M | ||
| Issuance (Repayment) of Debt Securities | -127.00K | ||
| Net Cash Flow from Operations | -15.90M | ||
| Share Based Compensation | 2.50M | ||